HypeXplace
During a recent charity auction held in Miami, Florida, F.P. Journe, in partnership with Phillips auction house, raised $420,000 USD in Support of the Breast Cancer Research Foundation (BCRF), through the sale of a single one-of-a-kind élégante 48mm Titalyt.
The sale, which saw 10 minutes of competitive bidding, set a new record for a non-diamond-set quartz watch and a new record for any piece in the élégante collection. Notably, 100 percent of the proceeds were directed to the BCRF, marking a significant contribution to the largest private funder of breast cancer research worldwide.
Expressing gratitude for the support, Donna McKay, BCRF’s President and CEO, said, “We are deeply grateful for F.P.Journe and Phillips’ extraordinary efforts which have helped to draw important attention to male breast cancer and fund critical research into a disease that affects one in 833 men in the U.S. By supporting BCRF, they are making an enormous impact in allowing our global legion of scientists to develop better approaches, treatments and outcomes for those with breast cancer and their loved ones.”
Phillips’ Head of Sale and International Specialist in Watches, Isabella Proia added “The Phillips team is immensely honored to have collaborated with F.P.Journe in offering this one-of-a-kind timepiece for such a noble cause. Standing witness to the vibrant energy in the room as collectors and philanthropists united for this mission was truly inspiring. With 100% of the proceeds benefiting the Breast Cancer Research Foundation, every bid represented a significant step forward in the fight against breast cancer.”
Notably, the élégante watch, which marks the 10th anniversary of its collection in 2024, is celebrated for its innovative electromechanical movement, designed to offer extensive autonomy and a unique hibernation feature that conserves battery life. The specific model sold during the charity auction is further distinguished in its uniqueness by a pink numeral “1” and strap, symbolizing the commitment to breast cancer research and awareness.
